Is AAPG or AARD more undervalued in 2026?

CirclFi compares Ascentage Pharma Group Internat (AAPG) and Aardvark Therapeutics, Inc. (AARD) using 13 institutional-grade valuation models. AAPG has a Quality of Company score of 4.7/10 while AARD scores 5.6/10.

Which is a better buy — AAPG or AARD?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do AAPG and AARD valuations compare?

AAPG at $20.01 and AARD at $4.11 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

AAPG vs AARD Valuation Comparison 2026 — Intrinsic Value Analysis

AAPG

Biotechnology

Ascentage Pharma Group Internat

Quality

4.7

out of 10

Value Trap

—

Price

$20.01

Last close

Models

12/13

Active

AARD

Biotechnology

Aardvark Therapeutics, Inc.

Quality

5.6

out of 10

Value Trap

—

Price

$4.11

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	AAPG Fair Value	AAPG Upside	AARD Fair Value	AARD Upside
Bayesian DCF	Intrinsic	$2.81	-86.0%	$2.43	-55.5%
Earnings Power Value	Intrinsic	$0.73	-96.9%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.00	-100.0%	$1.44	-65.0%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for AAPG vs AARD — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

AAPG vs AARD — Which Stock Is More Undervalued?

AARD scores higher with a 5.6/10 quality rating vs AAPG's 4.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Ascentage Pharma Group Internat (AAPG) and Aardvark Therapeutics, Inc. (AARD) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

AAPG currently trades at $20.01 with a QOC of 4.7/10, while AARD trades at $4.11 with a QOC of 5.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).